Inhibiting some nucleic acid molecules, such as lncRNA CTPB1-AS2, lncRNA NEAT1 and miR-93, can ameliorate cardiac hypertrophy by downregulating TLR4 signaling (57–119). Here, TLR4 is linked to cardiac hypertrophy.